Alnylam Pharmaceuticals Inc (ALNY) stock news · P/E 37, rev $3.71B
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
This ALNY news page leads with what Alnylam Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for ALNY yet. We will not pad this page with generic market recap.
Latest reported ALNY revenue for 2025-12-31 was $3.71B. Net income was $313.7M. Revenue was up 65.2% from 2024-12-31 to 2025-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 37.4.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ALNY stock page; for the tape open the quote page.
ALNY stock news FAQ
What are ALNY's latest revenue and net income?
Latest cached Alnylam Pharmaceuticals Inc (ALNY) revenue for Dec 31, 2025 was $3.71B. Net income was $313.7M. Statements: https://lician.com/financials/alny
How did ALNY revenue change from the prior cached period?
Cached Alnylam Pharmaceuticals Inc (ALNY) revenue was up 65.2% from $2.25B (Dec 31, 2024) to $3.71B (Dec 31, 2025). Statements: https://lician.com/financials/alny
What is ALNY's P/E ratio?
Alnylam Pharmaceuticals Inc (ALNY) trailing P/E is 37.4 on the latest cached fundamentals snapshot.
What is ALNY's market cap?
Alnylam Pharmaceuticals Inc (ALNY) market cap is $40.46B on the latest cached fundamentals snapshot.
What kind of company is ALNY?
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Where is ALNY stock news listed?
Cached stock news for Alnylam Pharmaceuticals Inc (ALNY) is listed at https://lician.com/news/alny. Filings: https://lician.com/sec/alny
Not investment advice.